Response from: James Hatton

I subscribe to your blog and have been enjoying your posts and perspective. I was looking back and saw your post on NexMed/Novartis deal, and I decided to check out the terms a little more. Your readers might be interested to know that NexMed may receive up to $51 million in upfront and milestone payments, including the $4M received at signing. Although the agreement is a relatively straightforward license, there are some interesting terms. Unusually, each of the milestones is set out in detail, instead of redacted. The terms on royalty reductions are more onerous than usual. Have a look.

Response from: ruth

thanks for the update, james! i'll just re-post your link for others to see (the comments section doesn't support html): http://www.jameshatton.com/public/2006/02/nexmednovartis-license-agree
ment.html

Response from: Zetaclear

Wow, I didn't know so many people were affected and so much is being spent on curing nail fungus. I'll definitely post this info on my site, proper credit will be given also.
http://www.homeopathicremediesfor.com/zetaclear-natural-remedy-for-nai
l-fungus.html